Cyborg | Designer-Babies | Futurism | Futurist | Immortality | Longevity | Nanotechnology | Post-Human | Singularity | Transhuman

Humacyte, a pioneer in regenerative medicine, today announced it will join U.S. Secretary of Commerce Penny Pritzker on a Development Mission to Japan and South Korea later this mo

Originally posted here:
Humacyte Selected to Join U.S. Secretary of Commerce On Trade Mission to Asia



Overview of Regenerative Medicine Partnering Merger Acquisition Market
The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine and stem cells partnering deals. The majority …

By: John Brown

Excerpt from:
Overview of Regenerative Medicine Partnering Merger & Acquisition Market – Video



Placenta Helps Heal Wounds
Using the placenta to help heal a patient's wounds. It's the latest wave in regenerative medicine. It's another option for doctors to treat patients with tough to heal open wounds, diabetic…

By: WTNH News8

More:
Placenta Helps Heal Wounds – Video

Osiris Therapeutics, Inc. , the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that it has entered into an exclusive commercial and development partnership for its cartilage product, Cartiform, with Arthrex, Inc.

Read more:
Osiris and Arthrex announce an exclusive partnership for the commercialization and development of Cartiform

Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, reported today that its proprietary iPSC Platelet technology is potentially cap

Read the rest here:
ACT Reports the Publication of Research on the Scalable Generation of Universal Platelets from Human Induced …



Regenestem Network Presentation
We are the largest membership network of Regenerative Medicine Clinics in the world, providing cutting edge care with the latest advancements in Cellular Therapies to patients Worldwide. Our…

By: StemCellsGroup

Continue reading here:
Regenestem Network Presentation – Video

The Alliance for Regenerative Medicine , along with its European sister organization, the Alliance for Advanced Therapies , today announced the leadership of both organizations has approved a Memorandum …

Read the original post:
The Alliance for Regenerative Medicine (ARM) and the Alliance for Advanced Therapies (AAT) Merge to Create One Unified …

Dr. David Dean of the Ohio State University Department of Plastic Surgery has been researching regenerative medicine for nearly two decades. His research during this time has made significant contributions …

Continue reading here:
Columbus Doctor Reveals Technological Advances in Regenerative Medicine

Osiris Therapeutics, Inc. , the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopa

Read this article:
Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds



Joy Silver on FAMI Fat Grafting at Empire Regen Centre
The FAMI Facial Fat Graft Volume Enhancement is done utilizing the world renowed FAMI technique. Dr Callanta is well versed with this technique after having done hundreds of cases over…

By: Empire Centre for Regenerative Medicine

Original post:
Joy Silver on FAMI Fat Grafting at Empire Regen Centre – Video



Mr. Seelan on FAMI Fat Grafting at Empire Regen CEntre
The FAMI Facial Fat Graft Volume Enhancement is done utilizing the world renowed FAMI technique. Dr Callanta is well versed with this technique after having done hundreds of cases over…

By: Empire Centre for Regenerative Medicine

Continue reading here:
Mr. Seelan on FAMI Fat Grafting at Empire Regen CEntre – Video



Ronnie Henares on FAMI Fat Grafting at Empire Regen Centre
The FAMI Facial Fat Graft Volume Enhancement is done utilizing the world renowed FAMI technique. Dr Callanta is well versed with this technique after having done hundreds of cases over…

By: Empire Centre for Regenerative Medicine

Go here to see the original:
Ronnie Henares on FAMI Fat Grafting at Empire Regen Centre – Video

Dr. Deepak Srivastava, a leading biomedical research policy expert, will discuss “Stem Cells, Regenerative Medicine and Policy Impediments to the New Future” at Rice University’s Baker Institute for Public Policy Oct. 21. The event is free and open to the public, but registration is required.

Who: Dr. Deepak Srivastava, the Baker Institute’s nonresident scholar for biomedical research policy and the Younger Family Director and senior investigator at the Gladstone Institute of Cardiovascular Disease.

Neal Lane, the Malcolm Gillis University Professor, senior fellow in science and technology policy at Rice’s Baker Institute for Public Policy and a professor of physics and astronomy, will give introductory remarks.

Stem cells and regenerative medicine are exciting and emerging fields of biomedical research, according to event organizers. Proposed applications include treating conditions such as blindness, diabetes and heart disease. Regenerative medicine could also help heal failing organ systems and replace damaged tissue. While these fields hold great promise for medicine, external factors limit and, in some cases, stall research, organizers said. Ethical controversies surrounding human embryonic stem cells, policy issues affecting federal and state funding and regulation, and economic pressures all play a role in determining the future of research.

In his presentation, Srivastava will explore the current and future potential of stem cells and regenerative medicine. Following the presentation, he will discuss policy challenges and opportunities with Lane.

The event is sponsored by the Baker Institute’s Science and Technology Policy Program and the Health Policy Forum.

See the original post here:
Stem cell, regenerative medicine policies to be discussed at Rice's Baker Institute

Regen BioPharma Inc. announced today the appointment of Dr. Amit Patel to the company's Scientific Advisory Board . Dr. Patel is Director of Clinical Regenerative Medicine and Tissue Engineering at the …

Go here to read the rest:
Cell Therapy Expert Dr. Amit Patel Joins Regen BioPharma Inc. Scientific Advisory Board

Dr. Deepak Srivastava, a leading biomedical research policy expert, will discuss “Stem Cells, Regenerative Medicine and Policy Impediments to the New Future” at Rice University’s Baker Institute for Public Policy Oct. 21. The event is free and open to the public, but registration is required.

Who: Dr. Deepak Srivastava, the Baker Institute’s nonresident scholar for biomedical research policy and the Younger Family Director and senior investigator at the Gladstone Institute of Cardiovascular Disease.

Neal Lane, the Malcolm Gillis University Professor, senior fellow in science and technology policy at Rice’s Baker Institute for Public Policy and a professor of physics and astronomy, will give introductory remarks.

What: A presentation titled “Stem Cells, Regenerative Medicine and Policy Impediments to the New Future.”

When: Tuesday, Oct. 21, 7:45-9:30 a.m. Breakfast will be served at 7:45.

Where: Rice University, James A. Baker III Hall, Kelly International Conference Facility, 6100 Main St.

Stem cells and regenerative medicine are exciting and emerging fields of biomedical research, according to event organizers. Proposed applications include treating conditions such as blindness, diabetes and heart disease. Regenerative medicine could also help heal failing organ systems and replace damaged tissue. While these fields hold great promise for medicine, external factors limit and, in some cases, stall research, organizers said. Ethical controversies surrounding human embryonic stem cells, policy issues affecting federal and state funding and regulation, and economic pressures all play a role in determining the future of research.

In his presentation, Srivastava will explore the current and future potential of stem cells and regenerative medicine. Following the presentation, he will discuss policy challenges and opportunities with Lane.

The event is sponsored by the Baker Institute’s Science and Technology Policy Program and the Health Policy Forum.

Read the original post:
Policy impediments to using stem cells and regenerative medicine to be discussed at Rice's Baker Institute Oct. 21

LAKE FOREST, Calif., Oct. 14, 2014 /PRNewswire/ — Cryoport, Inc. (CYRX) announced today the first phase of deploying its "Regenerative Medicine Point-of-Care Repository Solution" for Liventa Bioscience's introduction of Liventa's AmnioClear LCT therapy to orthopedic clinics in the US. According to one forecast, approximately $230 million of cell based biologic products for orthopedic uses were …

Originally posted here:
Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists

Tampa, FL (PRWEB) October 13, 2014

On Monday, October 20, Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee. RMS welcomes the launch of an entirely new facility, the Sleep Apnea Institute, and the expansion of a new treatment center for the Lung Institute. The new centers will be marked by an official ribbon cutting ceremony from the medical staff, RMS corporate team, and members of the Nashville Chamber of Commerce.

With the introduction of the Sleep Apnea Institute to Nashville, the hope is to bring awareness to those individuals that suffer from sleep apnea: both diagnosed and undiagnosed. Currently, there are 22 million Americans that suffer from sleep apnea, with 80 percent being undiagnosed. The Sleep Apnea Institute treats patients through a specialized procedure known as radiofrequency ablation.

With Nashville being a hub for medical technology, this was a prime location to expand the Lung Institute brand. After the current success of treating 400 patients at the clinic in Tampa, FL., the new expansion will bring stem cell treatments and innovative medicine to the Nashville area. Using stem cells from the patients own body, the Lung Institute treats lung diseases including pulmonary fibrosis and chronic obstructive pulmonary disease (COPD), a progressive disease that causes difficulty breathing.

Jack Coleman, Jr, MD, is the medical director of the Sleep Apnea Institute and the Lung Institute in Nashville. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is Board Certified in Otolaryngology and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

I am very excited about these new facilities opening, says Dr. Coleman. The Sleep Apnea Institute and the Lung Institute are providing innovative procedures for patients with debilitating conditions and will be a prime location for patients in Nashville.

Join us for the official ribbon cutting ceremony for the Sleep Apnea Institute and the Lung Institute, current Lung Institute patient will be available for questions:

When: Monday, October 20, 2014 at 10:00 a.m. Where: Sleep Apnea Institute & Lung Institute, 2001 Mallory Lane, Suite 302, Franklin, TN 37067

About Regenerative Medicine Solutions Regenerative Medicine Solutions (RMS) is a leading global provider of innovative regenerative technologies that treat an array of debilitating medical conditions. In addition, the company is the owner and operator of the Sleep Apnea Institute and the Lung Institute. Committed to an individualized patient-centric approach, RMS consistently provides the highest quality of care while producing positive outcomes. By applying modern-day best practices to the growing field of regenerative medicine, RMS is changing lives. For more information, visit our website at myregenmed.com, like us on Facebook, or follow us on Twitter or call us today at 1-877-867-4551.

###

Read more:
Regenerative Medicine Solutions Establishes Two New Clinics

RANCHO CORDOVA, Calif. and SYRACUSE, N.Y. — Cesca Therapeutics Inc. , an autologous cell-based regenerative medicine company, today announced that the Company has successfully secured a contract to provide …

See the rest here:
Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank

MIAMI (PRWEB) October 13, 2014

Regenestem, one of the largest membership networks of regenerative medicine clinics worldwide, has announced the launch of a new stem cells clinic in Antofagasta, Northern Chile. The clinic, to be headed by renowned stem cell specialists DRA Maria G. Soledad Gonzalez and Angel Gallegos Freire, M.D., will provide the latest advancements in stem cell treatments and protocol for a variety of eye conditions and diseases including macular degeneration and retinitis pigmentosa, as well as the latest anti-aging and aesthetic treatments and therapies.

Soledad Gonzalez specializes in opthamology at the Laser Surgery Clinic in Higher Vision of Antofagasta since 2003, where he focuses on refractive surgery to treat conditions like myopia, hyperopia, astigmatism and presbyopia. He incorporated minimally invasive aesthetic medicine protocols to his practice in 2012 and specializes in the harvest, preparation, activation and application of stem cell therapies for a number of chronic degenerative diseases.

Gallegos Freire, Medical Director, Policlinico Bhpbilliton M: BHP Billiton Spencea in Ubicacin, Chile, specializing in aesthetic and anti-aging stem cell medicine. Gallegos Freire in an active member of the Argentina Society of Aesthetic Medicine (SOARME), Institutional Member of the Medical Association of Argentina (AMA), the Pan-American Society of Aesthetic Medicine (PASAM) and the Antiaging & Aesthetic Medicine International Society (AAAMISO).

The Antofagasta Regenestem clinic is the companys third international stem cell treatment center opened since Global Stem Cells Group opened the Regenestem Asia Clinic in Manila, Philippines in June and the Regenestem Mexico Clinic in Villahermosa Tabasco. These new, state-of-the-art regenerative medicine facilities join the company’s growing global presence that includes clinics in Miami, New York, Los Angeles and Dubai. Regenestem Asia facility marks the first Regenestem brand clinic in the Philippines.

The Global Stem Cells Group and Regenestem are committed to providing the highest of standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.

For more information, visit the Regenestem website, email info(at)regenstem(dot)com, or call 305-224-1858.

About Regenestem:

Regenestem, a division of the Global Stem Cells Group, Inc., provides stem cell treatments for a variety of diseases and conditions including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes and multiple sclerosis at various facilities worldwide. Each Regenestem clinic offers an international staff experienced in administering the leading cellular therapies available.

Regenestem is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. Regenestem clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.

More here:
Regenestem Names Renowned Stem Cell Specialists to Launch New Regenerative Medicine Clinic in Antofagasta, Northern …



Spinal Cord Injury and Stem Cell Clinical Trials: Whats the Latest?
Join California's Stem Cell Agency (CIRM) for a live Google Hangout about the latest progress in stem cell-based treatments for spinal cord injury. You don't need a Google+ account to watch…

By: California Institute for Regenerative Medicine

Read more from the original source:
Spinal Cord Injury and Stem Cell Clinical Trials: Whats the Latest? – Video



FireFox! Start Your Own Web Hosting Company
Web Hosting Advertise Here $10 a Month Affordable web-hosting
Pierre Teilhard De Chardin




Designer Children | Prometheism | Euvolution | Transhumanism

Sign up below for the Prometheism / Designer Children Discussion Forum

Subscribe to prometheism-pgroup

Powered by us.groups.yahoo.com